Gut-Liver Interactions: Basic and Clinical Concepts

List of principal contributors.-List of chairpersons.-Preface SECTION I: GENETICS AND IMMUNOLOGY IN INFLAMMATORY BOWEL DISEASES:1 Inflammatory bowel disease genotypes and phenotypes.-2 Abnormalities of cytokine regulation in the inflammatory bowel diseases.-3 Dendritic cells: key players in inflammatory bowel disease.-4 Lipids and inflammatory bowel disease: microsomal triglyceride transfer protein -- the new dimension?.-5 The intestinal epithelium and inflammatory bowel disease.-SECTION II: EVIDENCE-BASED TREATMENT IN INFLAMMATORY BOWEL DISEASE:6 Evidence-based therapy with aminosalicylates.-7 The practical use of steroids in inflammatory bowel disease.-8 Immunosuppressants: clinical use and molecular mechanism of action.-9 Biologicals: old and new ones.-SECTION III: DIFFICULT CASES IN INFLAMMATORY BOWEL DISEASES: 10 Management of extraintestinal disease in inflammatory bowel disease.-SECTION IV: INNATE IMMUNITY -- MICROBIAL PRODUCTS:11 Immunomodulatory properties of the gut microflora.-12 Defensis and other antimicrobial mediators.-13 State of the art lecture: Post-infectious irritable bowel syndrome: role of inflammation and gut flora.-SECTION V: GUT-LIVER INTERACTIONS -- BASIC AND CLINICAL ASPECTS: 14 The liver and its contribution to induction of oral tolerance.-15 Molecular regulation of lymphocyte homing between the liver and the gut.-16 Modern concepts of coeliac disease pathogenesis.-17 Hepatobiliary manifestations in inflammatory bowel disease.-SECTION VI: PRIMARY BILIARY CIRRHOSIS, CHOLESTASIS AND AUTOIMMUNE LIVER DISEASE: 18 Primary biliary cirrhosis and biliary destruction: 2005; a liver odyssey.-19 Primary biliary cirrhosis: clinical aspects.-20 Molecular mechanisms of cholestasis.-SECTION VII: PRIMARY SCLEROSING CHOLANGITIS, ALCOHOLIC STEATOHEPATITIS, NON-ALCOHOLIC STEATOHEPATITIS: 21 Basic concepts in primary sclerosing cholangitis: what can we learn from studies of its genetic basis.-22 Clinical concepts in primary sclerosing cholangitis.-23 Alcoholic liver diseases.-24 Should non-alcoholic fatty liver disease be treated differently in elderly patients?.-SECTION VIII: LIVER FAILURE AND TRANSPLANTATION: 25 Acute liver failure -- mechanisms of liver cell destruction.-26 Clinical management of acute liver failure.-27 Liver and bowel transplantation in 2005.-28 Established and novel methods for treating inflammatory diseases by inhibition of cytokines.-Index